Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENLIGHTEN-Early: ALKS 3831 vs Olanzapine on Body Weight in Young Adults
NCT03187769Phase 3Completed
- Sponsor
- Alkermes
- Start
- Jun 2017
- Primary completion
- Dec 2021
- Countries
- 12
01
Overview
A Phase 3 trial of olanzapine + samidorphan in schizophrenia, schizophreniform disorder, bipolar I disorder, sponsored by Alkermes. Started Jun 2017; status: completed.
02
Drugs
olanzapine + samidorphan
03
Conditions
schizophreniaschizophreniform disorderbipolar I disorder
Beyond the preview
Go deeper on NCT03187769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187769.